Shire reports first sales after neuroscience, rare disease split
In its 1Q18 earnings, Shire plc (LSE:SHP; NASDAQ:SHPG) released its first figures since splitting its neuroscience and rare disease businesses into two divisions (see BioCentury Extra, Jan. 9) . For the quarter, Shire's rare disease...